Addressing Unmet Medical Needs with Stem Cell Culture Supernatant: Drug Discovery Bio-Venture U-Factor Co., Ltd.
U-Factor® Solutoin for Unmet Medical Needs.
Bringing U-Factor® solution to the world.
Many diseases, such as ALS and Alzheimer's disease, still exist in the world without effective treatments. We are committed to continuously developing new drugs to address the unmet medical needs of these intractable diseases using our developed stem cell culture supernatant, U-Factor® solution.
Research and Development
Addressing Unmet Medical Needs with U-Factor® Solution
In July 2023, we discovered a stem cell culture supernatant with higher cellular activity than conventional ones. We established an automated culturing method for mass production and began offering it as a "cell activator," known as U-Factor® solution, while continuing further research and development.
- ALS (Amyotrophic Lateral Sclerosis)
- Glaucoma
- Dry Eye
- Post-Stroke Sequelae
- Alzheimer's Disease
- Cerebral Aneurysm
- Muscular Dystrophy
- Crohn's Disease
- Parkinson's Disease
Collaborative Research and Specific Clinical Research
We are conducting research on various topics in collaboration with research institutions.
Current Partners
News Release
-
Press Release
U-Factor® Solution Yields Groundbreaking miRNA Marker for Therapeutic Effect
-
U-Factor Co., Ltd. Signs Joint Research Agreement with Tokyo Women’s Medical University for the Development of Therapeutics Using U-Factor solution
-
Press Release
Commencement of Joint Research with Tokyo Jikei University School of Medicine